Ideaya Biosciences Inc [IDYA] stock prices are down -0.33% to $24.53 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IDYA shares have gain 4.87% over the last week, with a monthly amount glided 0.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ideaya Biosciences Inc [NASDAQ: IDYA] stock has seen the most recent analyst activity on September 04, 2025, when Citizens JMP initiated its Mkt Outperform rating and assigned the stock a price target of $41. Previously, Barclays started tracking the stock with Overweight rating on September 04, 2025, and set its price target to $40. On July 22, 2025, TD Cowen initiated with a Buy rating. Wells Fargo initiated its recommendation with a Overweight and recommended $44 as its price target on June 26, 2025. Stephens started tracking with a Overweight rating for this stock on November 18, 2024, and assigned it a price target of $51. In a note dated November 05, 2024, Leerink Partners downgraded an Market Perform rating on this stock but restated the target price of $27.
The stock price of Ideaya Biosciences Inc [IDYA] has been fluctuating between $13.45 and $37.80 over the past year. Currently, Wall Street analysts expect the stock to reach $38.75 within the next 12 months. Ideaya Biosciences Inc [NASDAQ: IDYA] shares were valued at $24.53 at the most recent close of the market. An investor can expect a potential return of 57.97% based on the average IDYA price forecast.
Analyzing the IDYA fundamentals
Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -54.89%, Pretax Profit Margin comes in at -47.29%, and Net Profit Margin reading is -47.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.31 and Total Capital is -0.39. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Ideaya Biosciences Inc [NASDAQ:IDYA]’s Current Ratio is 12.39. In addition, the Quick Ratio stands at 12.39 and the Cash Ratio stands at 2.07. Considering the valuation of this stock, the price to sales ratio is 307.12, the price to book ratio is 2.24.
